Ensol Bioscience
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects (NCT05701644) | Ensol Bioscience | 2023-01-02 |
| E1K Intra Articular(IA) Treatment for Knee Osteoarthritis (NCT05697952) | Ensol Bioscience | 2022-06-13 |
Track Ensol Bioscience automatically
Every clearance here is in the API, with alerts when new ones post.